New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohort

Koren, O; Patel, V; Naami, R; Naami, E; Nagasaka, T; Shechter, A; Natanzon, SS; Kohan, S; Allison, Z; Lerner, A; Cheng, DE; Chakravarty, T; Nakamura, M; Cheng, W; Jilaihawi, H; Makkar, RR

Makkar, RR (通讯作者),Smidt Heart Inst, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.

FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022; 9 ():

Abstract

ObjectiveTo assess the incidence of new adverse coronary events (NACE) following transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR......

Full Text Link